Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | FBP1 | P09467 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzaldehyde SCHEMBL6051056 | 0.89 | ALDH1A1 (0.61) | ALDH1A1TSHRMAOBCYP2A6LMNA | |
| SCHEMBL9539397 | 0.85 | ALDH1A1 (0.41) | ALDH1A1LMNAHSP90AA1L3MBTL1MAPK1 | |
| SCHEMBL9541494 | 0.84 | NFE2L2 (0.52) | ALDH1A1TSHRFBP1ALOX15NFE2L2 | |
| SCHEMBL14269409 | 0.84 | ALDH1A1 (0.42) | ALDH1A1MAOBCYP2A6LMNAHSP90AA1 | |
| SCHEMBL9538596 | 0.84 | LMNA (0.42) | ALDH1A1TSHRCYP2A6LMNAFBP1 | |
| SCHEMBL24193844 | 0.84 | ESR1 (0.50) | ALDH1A1HSP90AA1CA2CA4CA5A | |
| SCHEMBL9541503 | 0.84 | TSHR (0.42) | TSHRMAOBCYP2A6LMNAFBP1 | |
| SCHEMBL14454720 | 0.82 | CA1 (0.47) | ALDH1A1TSHRHSP90AA1CA2FBP1 | |
| SCHEMBL9735648 | 0.80 | NFE2L2 (0.34) | ALDH1A1TSHRMAOBCYP2A6HSP90AA1 | |
| SCHEMBL14423637 | 0.80 | LTA4H (0.48) | ALDH1A1TSHRLMNAL3MBTL1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3970579-A | Low melting liquid-crystal mixtures | OWENS-ILLINOIS, INC. (US) | 1976-07-20 | — | — | US | claimed |
| CN-119504875-A | Synthetic method of ruthenium carbene complex | 江苏虹景新材料有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-105439901-B | Preparation method of 2-cyano-4'-methyl biphenyl | 浙江大学 | 2017-04-12 | — | — | CN | disclosed |
| US-20130084561-A1 | BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY | COULL JAMES M (US) | 2013-04-04 | — | — | US | disclosed |
| US-20130084561-A1 | BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY | COULL JAMES M (US) | 2013-04-04 | — | — | US | disclosed |
| US-8158631-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-04-17 | — | — | US | disclosed |
| CN-101979392-A | 7-arylethylene substituted high camptothecin compound and application thereof as medicament | UNIV PLA 2ND MILITARY MEDICAL | 2011-02-23 | — | — | CN | disclosed |
| EP-1340762-B1 | Cephalosporin synthesis | SANDOZ AG (CH) | 2011-02-16 | — | — | EP | disclosed |
| US-20100330032-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | CHIN ELBERT | 2010-12-30 | — | — | US | disclosed |
| US-20090149444-A1 | Benzylamine analogues | BTG INTERNATIONAL LIMITED (GB) | 2009-06-11 | — | — | US | disclosed |
| EP-0400972-A2 | Fluorescent degree of cure monitors | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4808572-A | ANTIALLERGENS | CIBA-GEIGY CORPORATION (US) | 1989-02-28 | — | — | US | disclosed |
| US-4785004-A | ANTIALLERGENS, ANTIHISTAMINES | CIBA-GEIGY CORPORATION (US) | 1988-11-15 | — | — | US | disclosed |
| US-4533657-A | Analgesic dipeptide amides and method of use and composition thereof | STERLING DRUG INC. (US) | 1985-08-06 | — | — | US | disclosed |
| US-4346101-A | NON-SEDATING | THE UPJOHN COMPANY (US) | 1982-08-24 | — | — | US | disclosed |
| US-4310716-A | NICKEL YLIDE CATALYST | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-01-12 | — | — | US | disclosed |
| US-4127455-A | Manufacture of symmetrical carotenoids | BASF AKTIENGESELLSCHAFT (DE) | 1978-11-28 | — | — | US | disclosed |
| US-4105855-A | Manufacture of symmetrical carotenoids | BASF AKTIENGESELLSCHAFT (DE) | 1978-08-08 | — | — | US | disclosed |
| US-4065620-A | ANTIBIOTICS | ELI LILLY AND COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
| US-3970579-A | Low melting liquid-crystal mixtures | OWENS-ILLINOIS, INC. (US) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330032-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | EIF2AK2, HCCS, RTF2 | ALDH1A1 597/4885TSHR 2301/4885MAOB 791/4885 |
| US-20090149444-A1 | Benzylamine analogues | HTR4, DRD4, SLC6A4 | ALDH1A1 910/4885TSHR 89/4885MAOB 36/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.